CardioKinetix has developed a novel transcatheter implant called the Parachute Ventricular Partitioning Device (Parachute). The Parachute is designed to be a catheter-based partitioning device deployed within the left ventricle for patients who have developed ischemic left sided heart failure following a heart attack. The Parachute implant partitions the damaged muscle, isolating the non-functional muscle segment from the functional segment, which decreases the overall volume and restores a more normal geometry and function in the left ventricle.
Latest funding size
Time since last funding
|over 2 years|
|U.S. Venture Partners (USVP), New Leaf Venture Partners, Panorama Capital, Lexington Partners, SV Life Sciences, Hambrecht & Quist Capital Management, Cutlass Capital, JPMorgan Partners (JPMP), Edwards Lifesciences, H&Q Healthcare Investors, Tekla Capital Management, SV Health Investors|